ATHENA published, FDA sets panel date for dronedarone in AF
Links shared publicly online about this topic.
- 2,262total visits
ATHENA published, FDA sets panel date for dronedarone in AF
The drug is envisioned as a safer alternative to amiodarone in patients with atrial fibrillation. (Hohnloser SH et al. N Engl J Med 2009; 360:668-678.)
View full resource at theheart.org
Tags: Atrial Fibrillation, Ear, Drug, FDA, Antiarrhythmic Medication, Multaq, Cordarone
Most Recently Shared on February 12, 2009 at 4:01 pm By:
ATHENA published, FDA readies to hear advisory panel on dronedarone for AF http://tinyurl.com/cn869q
Advertisement
